Applications of 2,4-Dichloro-6,7-Dimethoxyquinazoline in Industrial Manufacturing

As an established manufacturer of 2,4-Dichloro-6,7-Dimethoxyquinazoline, we support a range of specialized industries with reliable integration of this material into downstream production. The applications described below reflect actual use scenarios, with a focus on sector-specific processing, compliance, and formulation requirements.

1. Synthesis of Advanced Agrochemical Active Ingredients

This compound serves as a crucial building block in the production of selective herbicide intermediates, specifically during the synthesis of active compounds for rice, wheat, and maize pre- and post-emergent herbicides. Producers adopt this material due to its reactivity on the quinazoline ring, directly impacting the activity profile of the finished agrochemical. Formulation development typically occurs under tightly managed conditions to ensure the highest conversion efficiency and minimal by-product formation.

Industry compliance standards

• GB 2763—China’s National Food Safety Standard for Maximum Residue Limits for Pesticides
• European Union Regulation (EC) No 1107/2009 on plant protection products
• US EPA Product Chemistry Guidelines (OPPTS 830 Series)
• ISO 9001:2015 Quality Management System

Typical usage ratio

• Ranges from 3% to 7% of total active ingredient batch, adjusted according to the molecular pathway and target selectivity of the herbicide; process chemists account for side-chain functionalities when determining input ratio.

Downstream process integration

• Material is introduced in the nucleophilic substitution step, following pre-heating and active halogenation, prior to coupling with aromatic or heterocyclic amines; reaction proceeds in controlled solvent medium, often acetonitrile or DMF.

Final product types

• Pre-emergent herbicide technical concentrates
• Post-emergent selective herbicide water-dispersible granules
• Ready-to-use crop protection formulations
• Herbicide formulation intermediates for contract manufacturing

2. Pharmaceutical Intermediate for Kinase Inhibitor Synthesis

The chemical structure of this compound enables precise functionalization in the assembly of quinazoline-based API scaffolds, especially for kinase inhibitor molecules used in oncology. Leading pharmaceutical manufacturers source this raw material for multi-step synthesis routes, as its dichloro and methoxy substituents facilitate site-specific reactivity necessary for controlled API development within regulated environments.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) reference standards
• European Pharmacopoeia (Ph. Eur.) compliance for intermediates
• DQA/ICH Q3A Impurity Guidelines (for route selection and impurity control)

Typical usage ratio

• Used at 8% to 15% of the total mass of reactants in key cyclization and substitution steps; ratio depends on the desired quinazoline core substitution and downstream deprotection steps.

Downstream process integration

• Fed into the core quinazoline ring-forming reaction, typically after pre-activation with thionyl chloride or similar chlorinating agents; often used in conjunction with platinum-catalyzed coupling in API synthesis modules.

Final product types

• Targeted oncology API intermediates
• Research-grade small molecule libraries for kinase inhibition
• Clinical trial batch samples for investigational drugs
• Reference standard materials for GMP process validation

3. Fine Chemical Intermediates for Dye and Pigment Synthesis

Chemical companies engaged in the production of high-performance dyes utilize this material as a precursor in the synthesis of specialty pigment classes, such as methoxy-quinazoline-based chromophores. The dichloro and dimethoxy functional groups impart stability and colorfastness, supporting the formation of advanced dyes for industrial coatings and technical textiles where resistance properties are critical.

Industry compliance standards

• OEKO-TEX® Standard 100 for restricted substances in textiles
• REACH (EC 1907/2006) Registration for chemical intermediates
• EN 71-3: Safety of Toys—Migration of Certain Elements
• ISO 14001:2015 Environmental Management System (colorant production sites)

Typical usage ratio

• Used at 1% to 3% in dye formulation reactor loads; proportion varies depending on the required chromophore density and target shade in the end application.

Downstream process integration

• Dosed during the amination and coupling reaction, following initial diazotization or formylation steps; integration occurs in closed reactor systems under inert atmosphere to ensure consistent chromophore yield.

Final product types

• Textile reactive dyes for technical and performance fabrics
• Industrial pigment dispersions for coatings
• Specialty printing inks (UV-curable)
• Organic pigment masterbatches for plastics compounding

4. Electronic Chemical Intermediate for Liquid Crystal Materials

Manufacturers of advanced liquid crystal materials for display technologies employ this compound in the engineering of quinazoline-derived mesogenic units, which are essential for synthesizing nematic and smectic phase liquid crystals. Its chemical structure influences dielectric anisotropy and temperature stability, thereby enhancing the performance and longevity of LCD panels and related display devices.

Industry compliance standards

• RoHS Directive 2011/65/EU for restricted substances
• IEC 61249-2-21: Halogen-free electronic materials
• ISO 9001:2015 for electronic material production
• JEITA ET-7304 standards for liquid crystal materials

Typical usage ratio

• Typically added at 0.5% to 2% of batch mass for mesogen synthesis; exact input depends on chain length modification and temperature tolerance required by downstream display device specifications.

Downstream process integration

• Introduced during the functional group extension stage after base quinazoline ring assembly; subsequent halogen exchange and alkoxylation steps define the final mesogenic properties relevant for display performance.

Final product types

• Nematic and smectic liquid crystal mixtures for LCD
• Liquid crystal-based optical shutters
• Film retarders and polarizer plates for advanced displays
• Specialized liquid crystal prepolymers for flexible electronics

5. Intermediate in Synthesis of Specialty Fluorescent Markers

Chemical research enterprises and diagnostic reagent manufacturers use this compound as a core intermediate when constructing fluorescent markers for bioanalytical detection. Its substitution pattern supports strong electron donation, enabling efficient functionalization for conjugation to peptide or protein backbones in various bio-labeling technologies.

Industry compliance standards

• ISO 13485:2016 Medical Device Quality Management Systems (for diagnostic reagents)
• CLSI GP36—Validation of Fluorescent Labeling Reagents
• Good Laboratory Practice (OECD GLP) for analytical materials
• US FDA 21 CFR Part 820: Quality System Regulation

Typical usage ratio

• Recommended at 2% to 5% in total molar feed for labeling kits, adjusted to the intended detection wavelength and conjugation density for the diagnostic assay requirements.

Downstream process integration

• Added at the alkylation or esterification stage after initial quinazoline core formation, followed by directed ortho-substitution suitable for later bioconjugation; process ensures minimal side-product interference in the final analytical use.

Final product types

• Fluorescent tag reagents for immunoassays
• Peptide- and oligonucleotide-based diagnostic kits
• Bioimaging probe precursors
• Analytical standards for fluorescence-based detection systems